Aemetis’ (AMTX) Buy Rating Reiterated at HC Wainwright

Aemetis (NASDAQ:AMTX)‘s stock had its “buy” rating reissued by HC Wainwright in a report issued on Monday,Benzinga reports. They presently have a $28.00 price objective on the specialty chemicals company’s stock.

Separately, Ascendiant Capital Markets dropped their price target on Aemetis from $20.00 to $19.00 and set a “buy” rating for the company in a research note on Tuesday, September 3rd. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat.com, Aemetis presently has a consensus rating of “Moderate Buy” and a consensus target price of $12.95.

Aemetis Stock Performance

Shares of NASDAQ AMTX traded down $0.04 during midday trading on Monday, hitting $2.58. 363,165 shares of the company’s stock traded hands, compared to its average volume of 794,291. The stock has a market capitalization of $128.32 million, a price-to-earnings ratio of -1.14 and a beta of 1.35. The firm has a fifty day moving average of $3.30 and a 200 day moving average of $3.00. Aemetis has a 1 year low of $2.10 and a 1 year high of $7.03.

Aemetis (NASDAQ:AMTX) last posted its quarterly earnings data on Tuesday, November 12th. The specialty chemicals company reported ($0.38) EPS for the quarter, topping the consensus estimate of ($0.47) by $0.09. The company had revenue of $81.44 million during the quarter, compared to the consensus estimate of $77.79 million. During the same period last year, the business earned ($0.59) EPS. On average, equities analysts anticipate that Aemetis will post -2.02 earnings per share for the current year.

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of AMTX. Geode Capital Management LLC grew its holdings in shares of Aemetis by 7.7% in the third quarter. Geode Capital Management LLC now owns 924,293 shares of the specialty chemicals company’s stock worth $2,126,000 after purchasing an additional 66,031 shares during the last quarter. State Street Corp boosted its position in Aemetis by 36.1% in the 3rd quarter. State Street Corp now owns 699,089 shares of the specialty chemicals company’s stock valued at $1,608,000 after buying an additional 185,304 shares during the period. Susquehanna Fundamental Investments LLC grew its stake in Aemetis by 287.4% in the 2nd quarter. Susquehanna Fundamental Investments LLC now owns 126,078 shares of the specialty chemicals company’s stock worth $379,000 after acquiring an additional 93,536 shares in the last quarter. Bank of New York Mellon Corp bought a new stake in shares of Aemetis during the second quarter valued at approximately $306,000. Finally, Wellington Management Group LLP purchased a new stake in shares of Aemetis in the third quarter valued at approximately $177,000. Hedge funds and other institutional investors own 27.02% of the company’s stock.

Aemetis Company Profile

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.